BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Falbikitug readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Falbikitug\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05061550-2371@assetmemo.bio
DTSTAMP:20261121T004551Z
DTSTART;VALUE=DATE:20300528
DTEND;VALUE=DATE:20300529
SUMMARY:Falbikitug: Phase 2 readout est. (NCT05061550)
DESCRIPTION:Falbikitug\, phase 2\, Non-Small Cell Lung Cancer.\nStudy: Neoa
 djuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer\nE
 stimated primary completion: 28 May 2030. This is a ClinicalTrials.gov est
 imate\, not a confirmed readout date\, and it can move.\nDrug page: https:
 //assetmemo.bio/drug/falbikitug#upcoming-events\nRegistry record: https://
 clinicaltrials.gov/study/NCT05061550
URL:https://assetmemo.bio/drug/falbikitug#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
